Bookmark

Add to MyYahoo RSS

Biotime News

News on Biotime (Ticker: BTX) continually updated from thousands of sources around the net.

Thursday Aug 28 | Freshnews

BioTime to Collaborate With the University of Wisconsin and Louvain...

BioTime, Inc. today announced that it has entered into a collaboration with Susan Thibeault, Ph.D., of the University of Wisconsin and Marc Remacle, M.D. of Louvain University to evaluate BioTime's proprietary HyStem -based hydrogel for the treatment of vocal fold scarring.

Comment?

Related Topix: Startups, World News, Belgium, Stem Cell Research, Science / Technology

Thursday Aug 28 | Business Wire

Press release distribution, EDGAR filing, XBRL, regulatory filings

The Company is currently dra... BioTime to Collaborate With the University of Wisconsin and Louvain University in Test of HyStem-Based Hydrogel for Vocal Fold Scarring )--BioTime, Inc. today announced that it has entered into a collaboration with Susan Thibeault, Ph.D., of the University of Wisconsin and Marc Remacle,... )--Just in time for the ... (more)

Comment?

Related Topix: Marijuana, Startups, Phoenix Wright: Ace Attorney, Capcom, Video Games, Qualstar, Computers, Helen of Troy, Appliances

Wed Aug 27, 2014

Freshnews

BioTime Subsidiary Asterias Biotherapeutics Receives U.S. FDA...

BioTime, Inc. announced that its subsidiary Asterias Biotherapeutics, Inc. has received clearance from the U.S. Food and Drug Administration to initiate a Phase 1/2a clinical trial of its product, AST-OPC1, in patients with complete cervical spinal cord injury.

Comment?

Related Topix: Healthcare Law, Law, Startups, Food and Drug Administration

Thu Aug 21, 2014

Sys-Con Media

Asterias Biotherapeutics Appoints Two Independent Directors and...

With these additions, the Asterias Board of Directors now comprises eight directors, three of whom are independent.

Comment?

Related Topix: Marketing, Pfizer, Biotech, Healthcare Industry, Startups, Geron, Stem Cell Research, Science / Technology

Tue Aug 12, 2014

Freshnews

BioTime Announces Second Quarter 2014 Results and Recent Developments

BioTime, Inc. today reported financial results for the first quarter ended June 30, 2014 and highlighted recent corporate accomplishments.

Comment?

Related Topix: Startups, Healthcare Law, Law, Food and Drug Administration, Marketing, Stem Cell Research, Science / Technology

AmericanBankingNews.com

BioTime (BTX) Announces Quarterly Results

BioTime issued its quarterly earnings data on Tuesday. The company reported EPS for the quarter, StockRatingsNetwork reports.

Comment?

Related Topix: Startups

•••
•••
•••
•••

Woodbridge Jobs

•••
•••
•••
•••